Concord Medical Co., Ltd. (6518.TWO)

TWD 25.8

(0.0%)

EBITDA Summary of Concord Medical Co., Ltd.

  • Concord Medical Co., Ltd.'s latest annual EBITDA in 2023 was 137.47 Million TWD , down -4.06% from previous year.
  • Concord Medical Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was 28.82 Million TWD , down 0.0% from previous quarter.
  • Concord Medical Co., Ltd. reported an annual EBITDA of 143.46 Million TWD in 2022, up 0.81% from previous year.
  • Concord Medical Co., Ltd. reported an annual EBITDA of 142.32 Million TWD in 2021, up 5.44% from previous year.
  • Concord Medical Co., Ltd. reported a quarterly EBITDA of 28.82 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • Concord Medical Co., Ltd. reported a quarterly EBITDA of 26.3 Million TWD for 2023 Q1, down -30.12% from previous quarter.

Annual EBITDA Chart of Concord Medical Co., Ltd. (2023 - 2019)

Historical Annual EBITDA of Concord Medical Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 137.47 Million TWD -4.06%
2022 143.46 Million TWD 0.81%
2021 142.32 Million TWD 5.44%
2020 135.06 Million TWD 8.95%
2019 123.89 Million TWD 0.0%

Peer EBITDA Comparison of Concord Medical Co., Ltd.

Name EBITDA EBITDA Difference
St.Shine Optical Co.,Ltd. 1.01 Billion TWD 86.403%
Bioteque Corporation 736.13 Million TWD 81.325%
Chi Sheng Pharma & Biotech Co., Ltd 117.55 Million TWD -16.947%
Sunder Biomedical Tech. Co., Ltd. 76.61 Million TWD -79.44%
BenQ Medical Technology Corporation 532.15 Million TWD 74.166%
Pacific Hospital Supply Co., Ltd 673.8 Million TWD 79.597%
Unicon Optical Co., Ltd. 377.24 Million TWD 63.559%
Formosa Optical Technology Co.,Ltd. 1.04 Billion TWD 86.85%
Medeon Biodesign, Inc. -1.14 Billion TWD 112.039%
Crystalvue Medical Corporation 149.73 Million TWD 8.186%
Perfect Medical Industry Co., Ltd. 115.48 Million TWD -19.046%
ICARES Medicus, Inc. 165.54 Million TWD 16.955%
Lagis Enterprise Co., Ltd. 112.36 Million TWD -22.347%
Amed Co., Ltd. 157.32 Million TWD 12.618%